Javascript must be enabled to continue!
e0506 Application of overlapped sirolimus-eluting stents in treatment of long coronary arteries lesion
View through CrossRef
Objective
To evaluate the clinical efficacy of overlapped Excel and Cypher stents in treatment for long coronary arteries lesion.
Method
374 patients with de-novo long coronary arteries lesion who performed 2 Excel or Cypher stents which diameter varied 2.5 mm ∼ 3.5 mm in department of cardiology, general hospital of CAPF were enrolled in from 2006.8 to 2009.3 retrospectively. These patients were divided to two groups by the type of stents implanted: Excel group and Cypher group. The incidence of composite MACE and stent thrombosis during hospitalisation and 12-month clinical follow-up outside hospital after PCI between two groups were compared, follow-up angiograpy were performed in several patients, and in-stent LLL, in-segemt LLL and incidence of restenosis between two groups were compared.
Result
Clinical characteristics and characteristics of target lesion were similar between two groups, PCI procedure were similar except the ratio of pre-dilatation between two groups. Incidence of composite MACE during hospitalisation after PCI of Excel group and Cypher group were 5.7% and 6.1%, incidence of composite MACE 12-month clinical follow-up outside hospital were 6.6% and 8.8% respectively, incidence of acute/subacute stent thrombosis defined by ARC of Excel group and Cypher group were 2.8% and 2.5%, incidence of late stent thrombosis were 2.7% and 2.7% respectively, there were no significant differences between two groups; incidence of in-stent restenosis of Excel group and Cypher group follow-up were 6.0% and 9.6%, incidence of in-segment restenosis were 9.5% and 12% respectively, that revealed non-significant differences between two groups; in-segment LLL of Excel group and Cypher group were 0.11±0.06 mm and 0.12±0.08 mm, there were no significant differences between two groups, but in-stent LLL were 0.09±0.05 mm and 0.10±0.05 mm respectively, that showed significant difference between two groups (p=0.037).
Conclusion
The safety and efficacy of overlapped Excel stents were similar as overlapped Cypher stents in treatment of long coronary arteries lesion, meanwhile, overlapped Excel stents relieve in-stent LLL than overlapped Cypher stents; LLL of overlapped site was more severe than non-overlapped site, whatever Excel or Cypher stents, but there was no significant difference in ratio of restenosis between overlapped site and any other regions.
Title: e0506 Application of overlapped sirolimus-eluting stents in treatment of long coronary arteries lesion
Description:
Objective
To evaluate the clinical efficacy of overlapped Excel and Cypher stents in treatment for long coronary arteries lesion.
Method
374 patients with de-novo long coronary arteries lesion who performed 2 Excel or Cypher stents which diameter varied 2.
5 mm ∼ 3.
5 mm in department of cardiology, general hospital of CAPF were enrolled in from 2006.
8 to 2009.
3 retrospectively.
These patients were divided to two groups by the type of stents implanted: Excel group and Cypher group.
The incidence of composite MACE and stent thrombosis during hospitalisation and 12-month clinical follow-up outside hospital after PCI between two groups were compared, follow-up angiograpy were performed in several patients, and in-stent LLL, in-segemt LLL and incidence of restenosis between two groups were compared.
Result
Clinical characteristics and characteristics of target lesion were similar between two groups, PCI procedure were similar except the ratio of pre-dilatation between two groups.
Incidence of composite MACE during hospitalisation after PCI of Excel group and Cypher group were 5.
7% and 6.
1%, incidence of composite MACE 12-month clinical follow-up outside hospital were 6.
6% and 8.
8% respectively, incidence of acute/subacute stent thrombosis defined by ARC of Excel group and Cypher group were 2.
8% and 2.
5%, incidence of late stent thrombosis were 2.
7% and 2.
7% respectively, there were no significant differences between two groups; incidence of in-stent restenosis of Excel group and Cypher group follow-up were 6.
0% and 9.
6%, incidence of in-segment restenosis were 9.
5% and 12% respectively, that revealed non-significant differences between two groups; in-segment LLL of Excel group and Cypher group were 0.
11±0.
06 mm and 0.
12±0.
08 mm, there were no significant differences between two groups, but in-stent LLL were 0.
09±0.
05 mm and 0.
10±0.
05 mm respectively, that showed significant difference between two groups (p=0.
037).
Conclusion
The safety and efficacy of overlapped Excel stents were similar as overlapped Cypher stents in treatment of long coronary arteries lesion, meanwhile, overlapped Excel stents relieve in-stent LLL than overlapped Cypher stents; LLL of overlapped site was more severe than non-overlapped site, whatever Excel or Cypher stents, but there was no significant difference in ratio of restenosis between overlapped site and any other regions.
Related Results
Crush Stenting With Paclitaxel-Eluting or Sirolimus-Eluting Stents for the Treatment of Coronary Bifurcation Lesions
Crush Stenting With Paclitaxel-Eluting or Sirolimus-Eluting Stents for the Treatment of Coronary Bifurcation Lesions
Two hundred forty-six patients with 252 bifurcation lesions were enrolled into a prospective, nonrandomized study to use paclitaxel-eluting or sirolimus-eluting stent for crush ste...
CLINICAL APPLICATION OF DOMESTIC LONG BIODEGRADABLE POLYMER COATED SIROLIMUS ELUTING STENTS FOR TREATMENT OF LONG CORONARY ARTERY LESIONS
CLINICAL APPLICATION OF DOMESTIC LONG BIODEGRADABLE POLYMER COATED SIROLIMUS ELUTING STENTS FOR TREATMENT OF LONG CORONARY ARTERY LESIONS
Objectives
To evaluate the efficacy and safety of domestic long biodegradable polymer coated sirolimus eluting stents (Excel stent, Shandong JW) for treatment of ...
In-stent restenosis in the drug-eluting stent era
In-stent restenosis in the drug-eluting stent era
For the last two decades, restenosis has been considered the most significant problem in interventional cardiology. Drug-eluting stents (DES) have reduced rates of restenosis and t...
e0517 Forearm arteries with ultrasound for percutaneous coronary procedures
e0517 Forearm arteries with ultrasound for percutaneous coronary procedures
Background
The radial artery has become a widely used approach for coronary angiography and intervention in patients, and the ulnar artery is another approach for...
Drug-eluting stents: new era and new concerns
Drug-eluting stents: new era and new concerns
Abstract
At present there is much excitement about drug-eluting stents, which hold promise for the treatment of coronary artery disease. This ingenious therapy invol...
GW24-e0529 Impact on endothelial repair after novel fully biodegradable drug-eluting scaffold implanted in porcine coronary model
GW24-e0529 Impact on endothelial repair after novel fully biodegradable drug-eluting scaffold implanted in porcine coronary model
Objectives
To observe the impact on endothelial repair of structure and function after novel fully biodegradable drug-eluting stent implanted in mini-pigs coronar...
Effectiveness and safety of the sirolimus‐eluting stents coated with bioabsorbable polymer coating in human coronary arteries
Effectiveness and safety of the sirolimus‐eluting stents coated with bioabsorbable polymer coating in human coronary arteries
AbstractBackground: Although the sirolimus‐eluting stent (CYPHER®, Cordis, USA) has shown a dramatic reduction of restenosis, there are still some concerns about its efficacy and s...
e0543 Clinical and coronary angiography characteristics between young (<45) and old (>60) patients with coronary artery disease
e0543 Clinical and coronary angiography characteristics between young (<45) and old (>60) patients with coronary artery disease
Objective
To study the clinical Clinical and coronary angiography characteristics between young (≤45) and old (>60) patients with coronary artery disease.
...


